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INTRODUCTION
Prescribing is the major therapeutic 
intervention available to clinicians, with 
most occurring in primary care where 
long-term conditions are increasingly 
managed. Medication use is steadily 
growing: the proportion of UK patients 
receiving ≥5 drugs doubled between 
1995 and 2010.1 Prescribing of multiple 
medications (polypharmacy) is driven 
by several factors, including an ageing 
population, multimorbidity, and single-
condition, guideline-driven prescribing.2,3 
Polypharmacy is, in turn, associated with 
medication errors,4 adverse reactions,5 
a reduced quality of life,6 and impaired 
medication adherence.7 
Care transitions can impact on the 
quality and continuity of pharmacotherapy. 
Previous research has found that many 
patients experience changes to their 
medication regimen after hospitalisation,8 
with extensive changes occurring at 
discharge,9,10 including increases in the 
number of potentially inappropriate 
prescriptions (PIPs),11,12 where the risks 
associated with a prescription outweigh the 
benefits, such as prescribing in the context 
of a recognised contraindication.11–13 Given 
differences in health service structures 
and processes, it is unknown whether 
these issues are observed in UK practice. 
Furthermore, previous work has had 
important limitations, including relatively 
small populations, limited clinical focus, or 
ecological methods. 
Improving understanding of changes 
in medication following hospitalisation 
is relevant as it can inform medicine 
reconciliation, an important and improvable 
aspect of high-quality care.14 This study aimed 
to examine the effect of a single emergency 
admission on changes in overall prescribing 
and PIPs in UK primary care, including how 
this varies with hospital specialty.
METHOD
Study population
A descriptive analysis was conducted 
using anonymised data from the Clinical 
Practice Research Datalink (CPRD).15 The 
CPRD is a database of anonymised UK 
primary care electronic health records, 
containing >5 million active patients from 
approximately 650 general practices, and is 
representative of the general population.15,16 
The database contains coded data on clinical 
diagnoses and prescribed medications. 
A random sample of 100 000 patients 
(the maximum available to the study), 
aged ≥18 years, admitted to hospital in 
2014, was identified using linked Hospital 
Episode Statistics (HES) data. Analysis was 
restricted to emergency admissions. HES 
contains coded data (dates, diagnoses, 
hospital specialty) on most English hospital 
inpatient admissions.17 The first hospital 
admission, including readmissions within 
6 weeks of discharge, was defined as the 
index admission. Patients were excluded if 
hospitalised within 1 year before the index 
admission to ensure changes to prescriptions 
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Abstract
Background
Little is known about the impact of hospitalisation 
on prescribing in UK clinical practice.
Aim
To investigate whether an emergency hospital 
admission drives increases in polypharmacy and 
potentially inappropriate prescriptions (PIPs). 
Design and setting
A retrospective cohort analysis set in primary and 
secondary care in England.
Method
Changes in number of prescriptions and PIPs 
following an emergency hospital admission in 
2014 (at admission and 4 weeks post-discharge), 
and 6 months post-discharge were calculated 
among 37 761 adult patients. Regression models 
were used to investigate changes in prescribing 
following an admission.
Results
Emergency attendees surviving 6 months 
(N = 32 657) had a mean of 4.4 (standard deviation 
[SD] = 4.6) prescriptions before admission, and 
a mean of 4.7 (SD = 4.7; P<0.001) 4 weeks after 
discharge. Small increases (<0.5) in the number 
of prescriptions at 4 weeks were observed 
across most hospital specialties, except for 
surgery (–0.02; SD = 0.65) and cardiology (2.1; 
SD = 2.6). The amount of PIPs increased after 
hospitalisation; 4.0% of patients had ≥1 PIP 
immediately before pre-admission, increasing 
to 8.0% 4 weeks post-discharge. Across hospital 
specialties, increases in the proportion of patients 
with a PIP ranged from 2.1% in obstetrics and 
gynaecology to 8.0% in cardiology. Patients were, 
on average, prescribed fewer medicines at 
6 months compared with 4 weeks post-discharge 
(mean = 4.1; SD = 4.6; P<0.001). PIPs decreased 
to 5.4% (n = 1751) of patients.
Conclusion
Perceptions that hospitalisation is a consistent 
factor driving rises in polypharmacy are 
unfounded. Increases in prescribing post-
hospitalisation reflect appropriate clinical 
response to acute illness, whereas decreases 
are more likely in patients who are multimorbid, 
reflecting a focus on deprescribing and medicines 
optimisation in these individuals. Increases in 
PIPs remain a concern.
Keywords
hospital admission; hospital emergency service; 
inappropriate prescribing; polypharmacy; primary 
health care. 
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were not influenced by previous hospital 
stays. Maternity admissions specifically 
relating to childbirth were excluded. 
Measurements
The number of (ongoing) prescriptions 
were ascertained at index admission, and 
at 4 weeks and 6 months post-discharge. 
An ongoing prescription was defined as 
one where the period of time over which 
it was used included the date of interest. 
Prescription length was calculated by 
dividing drug quantity by number of daily 
doses; where missing, a population average 
was used. Prescriptions were categorised 
according to the British National Formulary 
(BNF),18 and limited to pharmacological 
products (BNF chapters 1–15). 
Counts of all ongoing prescriptions were 
calculated at each time point, stratified 
by BNF chapter. A categorical count of all 
ongoing prescriptions of unique drugs at 
index admission based on pragmatic and 
clinical judgement was created, grouping 0, 
1–3, 4–6, 7–9, 10–14, and ≥15 prescriptions. 
Two continuous measures detailing the 
change in number of prescriptions relative 
to index admission in the short term 
(4 weeks) and long term (6 months) were 
created and grouped into five categories 
(reductions of 1 drug, or ≥2 drugs, no 
change, increases of 1 drug, or ≥2 drugs). 
PIPs were based on 19 Royal College of 
General Practitioners (RCGP) inappropriate 
prescribing indicators,19,20 which were used 
in the PINCER trial21 and that are currently 
being implemented in UK clinical practice. 
These indicators included prescribing in 
the context of particular contraindications, 
for example, beta-blockers and asthma, or 
drug–drug interactions, such as warfarin 
with non-steroidal anti-inflammatory drugs 
(NSAIDs).19 Binary measures detailing 
whether the patient had ≥1 PIP at the index 
admission at 4 weeks and 6 months post-
discharge were created.
Hospital specialty, that with primary 
responsibility for patient care, was based 
on the longest episode of care during a 
given admission and grouped according to 
national patterns22 (Supplementary Table S1). 
Individual specialties, that is, gastrointestinal/
respiratory, were grouped together, except 
for cardiology after initial investigation found 
little differences in prescribing across specific 
specialties. Duration of index hospitalisation 
was also calculated along with number of 
readmissions and number of admissions 
within 6 months of discharge. A list of 37 
physical and mental long-term conditions 
established by clinical expert consensus 
was used to ascertain comorbidity status 
at hospitalisation.23–25 A simple, unweighted 
count of clinical conditions was derived, and 
a six-category measure (0–≥5 conditions) 
created. 
How this fits in 
Evidence from Australia, Canada, and 
Europe suggests transitions between 
primary and secondary care impact on 
the quality and continuity of medication 
therapy. Findings from this study, the first, 
to the authors' knowledge, to investigate 
the impact of an emergency hospital 
admission on changes to prescribing in 
primary care in England, indicate that 
prescribing increases after discharge, but 
then falls to pre-hospital levels 6 months 
later. Potentially inappropriate prescribing 
increases following a hospital admission, 
both in the short and long term.
Table 1. Characteristics of patients having an emergency admission to 
hospital, N = 32 657a
Characteristic n (%)b
Sex
 Male 15 027 (46.0)
 Female 17 630 (54.0) 
Age at admission, years
 Mean (SD) 58.7 (21.3)
 Median (IQR) 60 (41 to 77)
Multimorbidity scores
 0 8648 (26.5)
 1 7463 (22.9)
 2 6424 (19.7)
 3 4542 (13.9)
 4 2797 (8.6)
 ≥5 2783 (8.5) 
Number of prescriptions before hospitalisation
 0 8466 (25.9) 
 1–3 6345 (19.4) 
 4–6 4691 (14.4) 
 7–9 8407 (25.7)
 10–14 3647 (11.2)
 ≥15 1101 (3.4)
Index hospitalisation factors
 Duration of hospitalisation, days 
  Mean (SD) 6.4 (17.0)
  Median (IQR) 2 (0 to 6)
 Number of admissions during hospitalisation
  Mean (SD) 1.4 (2.4)
  Median (IQR) 1 (1 to 1)
 Number of admissions within 6 months of discharge
  0 25 189 (77.1)
  1 5125 (15.7)
  ≥2 2343 (7.2)
aIndex hospital admission defined as first hospitalisation of 2014 (with no hospitalisation in the previous 6 months) 
and includes any hospital admissions within 6 weeks of discharge. Multimorbidity list includes 37 chronic 
conditions.23 bUnless otherwise stated. IQR = interquartile range. SD = standard deviation. 
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Statistical analysis
Descriptive analyses were used to explore 
prescribing patterns before and after the 
index admission. Analyses were restricted 
to patients who survived 6 months post-
discharge. Multilevel linear regression 
models were fitted to the outcomes 
(change in number of prescriptions at 
4 weeks compared with at index admission; 
6 months compared with 4 weeks post-
discharge) by hospital specialty. Marginal 
effects were estimated and represent a 
change in the number of prescriptions by 
the exposure of interest, keeping other 
covariates at their observed levels, and 
averaged across patients. Multilevel logistic 
regression was used to calculate odds 
ratios (ORs) and 95% confidence intervals 
(CIs) of having a PIP at 4 weeks compared 
with index admission, and at 6 months 
compared with 4 weeks post-discharge, 
by hospital specialty. In both models, 
covariates were included as fixed effects, 
with a random intercept term for general 
practice to adjust for clustering. Age and 
number of prescriptions at index admission 
were standardised using respective sample 
mean values and standard deviations 
(SD). All continuous measurements 
were grouped into relevant categories or 
quartiles. Interaction terms were used to 
investigate non-linear associations and 
the most appropriate, as determined using 
likelihood ratio tests, are presented. Data 
analysis was conducted in Stata (version 
15). Statistical tests were two-sided.
Sensitivity analysis
The authors repeated models, including all 
patients alive at 4 weeks post-discharge, 
to assess whether restricting analysis 
to patients who survived 6 months post-
discharge biased the estimates. Regression 
to the mean (extreme values moving towards 
the average when measured repeatedly on 
the same subject) was explored across 
grouped number of prescriptions before 




A total of 37 761 emergency attendances 
were found, of which 34 815 and 32 657 
were alive at 4 weeks and 6 months 
post-discharge, respectively. On average, 
patients who survived at 6 months post-
discharge, compared with patients who 
died (n = 5115), had fewer prescriptions 
at hospitalisation (mean = 4.4; SD = 4.6 
versus mean = 6.3; SD = 4.7), and fewer 
comorbidities (≥5 conditions: 8.5% versus 
18.1%; P<0.001). For those patients 
surviving 6 months, hospital emergency 
attendees had a mean age of 58.7 (SD = 21.3) 
years, 54.0% were female, and 50.7% had 
≥2 comorbidities (Table 1). Average duration 
of hospitalisation was 2 days (interquartile 
range = 0 to 6), and 22.9% of patients 
were re-admitted within 6 months post-
discharge.
Number of prescriptions following 
hospital discharge
Emergency attendees had a mean of 4.4 
(SD = 4.6) prescriptions before admission 
and a mean of 4.7 (SD = 4.7; P<0.001) 
4 weeks after discharge. Following 
hospitalisation, increases in prescribing 
were observed in all patients across sex, age, 
and multimorbidity status (Supplementary 
Figure S1). 
Patients prescribed fewer medications 
before a hospital admission were prescribed 
more after, whereas those prescribed more 
received fewer following hospitalisation. 
Observed findings were compatible with 
regression to the mean (Supplementary 
Table S2). 
The number of drugs pre-hospitalisation 
varied across hospital specialties (Figure 1). 
Small increases (<0.5) in the number of 
prescriptions at 4 weeks post-discharge, 
compared with pre-admission, were 
observed for most specialties, except for 
surgery (–0.02; SD = 0.65) and cardiology 
(2.1; SD = 2.6).
Overall, 57.1% (n = 18 636) of patients had 
a change in the number of prescriptions 
following hospitalisation, ranging from 
51.0% in obstetrics and gynaecology 
(O&G) (n = 721/1415) to 83.5% in cardiology 
(n = 1269/1520) (Figure 2). Of those patients 
treated in cardiology, 53.7% (n = 816) had 
≥2 additional prescriptions. Admissions 
under O&G had the greatest proportion 
of patients with ≥2 fewer prescriptions at 
4 weeks post-discharge at 6.5% (n = 92). 
In adjusted models, the average change 
in number of prescriptions following 
hospitalisation was relatively small (<0.5) 
across most specialties (Supplementary 
Figure S2). Only surgery showed a 
slight decrease in prescribing (–0.17; 
95% CI = –0.24 to –0.09). Cardiology 
demonstrated a marked increase of 2.16 
(95% CI =  2.04 to 2.27) prescriptions.
Potentially inappropriate prescribing 
following hospital discharge
There was an increase in the proportion 
of patients who had PIPs from 4.0% pre-
admission to 8.0% immediately at 4 weeks 
post-discharge (Figure 3). The most marked 
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increases were observed for patients with 
a history of heart failure and prescribed an 
NSAID (RCGP indicator 6) (3.0%; n = 12/403 
to 7.4%; n = 139/1890), and patients 
prescribed warfarin and aspirin without 
gastroprotection (RCGP indicator 10) (0.8%; 
n = 8/944 to 4.2%; n = 47/1123). Similar 
patterns were observed across hospital 
specialty, with increases ranging from 0.9% 
to 3.0% in O&G and from 5.5% to 13.4% in 
cardiology.
In adjusted models, the OR of receiving 
a PIP was 2.01 (95% CI = 1.93 to 2.23) at 
4  weeks post-discharge, compared with 
pre-admission. The risk of having a PIP was 
comparable across most hospital specialties 
(Supplementary Figure S3), except for O&G 
for which the risk was higher owing to low 
pre-admission prescribing.
Sustained changes in prescribing 
6 months after hospitalisation
Fewer medicines were prescribed at 
6 months post-discharge than at pre-
admission and at 4 weeks post-discharge 
(mean = 4.1; SD = 4.6); 60.4% of patients 
(n = 19 726) had ≥1 additional or removed 
medication, compared with 4 weeks 
post-discharge (Figure 4). Decreases in 
prescribing at 6 months were observed 
in older patients, those diagnosed 
with ≥3 comorbidities, and patients 
prescribed ≥7 medicines at hospitalisation 
(Supplementary Figure S4). The latter was 
lower than expected given regression to the 
mean estimates (Supplementary Table S2). 
The decrease in medicines at 6 months, 
compared with immediately post-discharge, 
persisted across specialties (Figure 1), 
ranging from 0.2 (SD = 1.6) in O&G to 0.9 
(SD = 3.5) in both cardiology and other 
medicines. In an adjusted model, the 
average patient was prescribed 0.77 (95% 
CI = 0.63 to 0.92) fewer medications at 
6 months, compared with 4 weeks post-
discharge (Supplementary Figure S5). PIPs 
decreased to 5.4% of patients (n = 1751) by 
6 months, though this was still higher than at 
admission. After adjusting, the OR for a PIP 
at 6 months compared with one at 4 weeks 
post-discharge was 0.70 (95% CI = 0.66 to 































































































































Figure 1. Mean number of prescriptions before and 
after hospitalisation stratified by hospital specialty 
and BNF chapter. Index hospital admission defined as 
first hospitalisation of 2014 (with no hospitalisation 
in the previous 6 months) and includes any hospital 
admissions within 6 weeks of discharge. Patients 
restricted to those who were still alive 6 months 
post-discharge (N = 32 657). Hospital specialty based 
on longest episode of care and grouped according 
to national frequency emergency admissions 
(Supplementary Table S1). 
BNF = British National Formulary. CNS = central 
nervous system. CV = cardiovascular. 
GI = gastrointestinal. MSK = musculoskeletal. 









































Reduction ≥2 Reduction of 1
Type of prescription change 
No change Increase 1 Increase ≥2
Other
Figure 2. Change in total number of prescriptions at 
4 weeks post-discharge compared with hospitalisation 
among emergency attendees stratified by hospital 
specialty. Index hospital admission defined as first 
hospitalisation of 2014 (with no hospitalisation in 
the previous 6 months) and includes any hospital 
admissions within 6 weeks of discharge. Number of 
prescriptions includes all ongoing prescriptions on the 
date of interest. Patients restricted to those who were 
still alive 6 months post-discharge (N = 32 657).  
O&G = obstetrics and gynaecology.
British Journal of General Practice, June 2020  e402
Sensitivity analysis
No differences were observed when analysis 
was repeated including all patients alive at 
4 weeks post-discharge (data not shown).
DISCUSSION
Summary
This study is the first to assess the impact 
of emergency hospitalisation on prescribing 
in primary care in the general English 
population, finding that overall prescribing 
increased following discharge but fell to 
below pre-hospital levels within 6 months. 
There was little variation in prescribing 
changes across hospital specialty, 
except for cardiology admissions where 
statistically significant long-term increases 
in prescribing were observed. Overall, PIPs 
increased following a hospital admission, 
both in the short and long term.
Hospitalisation is associated with 
significant changes to medication regimens, 
particularly for certain patient groups 
and hospital specialties. Perceptions 
that a hospital admission is a consistent 
factor driving rises in polypharmacy are 
unfounded. Increases in PIPs remain a 
concern. Health services need to consider 
improved, targeted medication optimisation 
strategies for those patients discharged 
from hospital who are most likely to 
experience changes to their medications.
Strengths and limitations
To the authors' knowledge, this is one of 
the largest studies to investigate changes 
in prescribing following emergency 
hospitalisation, to explore differences by 
hospital specialty, and include younger 
patients. Detailed data on medical history, 
all primary care prescribing (as electronic 
prescribing is ubiquitous in the UK), and 
hospital admissions were available. 
An important first limitation was that 
actual discharge prescriptions could not be 
determined but rather what the GP elected 
to prescribe post-discharge, which might 
not reflect hospital recommendations. 
Nevertheless, this study provides detailed 
insights into changes that occur shortly 
after discharge, which are highly relevant 
























































































































Figure 3. Percentage of patients who had ≥1 potentially 
inappropriate prescription (PIP) pre-hospitalisation 
at 4 weeks and at 6 months post-discharge stratified 
by hospital specialty. Prescribing safety indicator 
(composite measure of indicators P1–P19)19 used to 
identify potentially inappropriate prescribing. Patients 
restricted to those who were still alive at 6 months 
post-discharge. 









































Reduction ≥2 Reduction of 1
Type of prescription change 
No change Increase 1 Increase ≥2
Other
Figure 4. Change in total number of prescriptions at 
6 months post-discharge compared with at 4 weeks 
post-discharge, among emergency attendees, stratified 
by hospital specialty. Index hospital admission defined 
as first hospitalisation of 2014 (with no hospitalisation 
in the previous 6 months) and includes any hospital 
admissions within 6 weeks of discharge. Thus, 
discharge date is based on last hospital admission. 
Number of prescriptions includes all ongoing 
prescriptions on the date of interest. Patients restricted 
to those who were still alive 6 months post-discharge 
(N = 32 657).
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Second, there is no single accepted means 
of quantifying amount or appropriateness of 
medicine use in routine data. The measure 
in this study is thus a compromise, including 
broad counts of medicines that provide 
little insight into appropriateness and 
narrower specific measures of PIPs that 
are already used to inform UK medicines 
optimisation. In addition, PIPs may be offset 
by therapeutic benefits, but assessing the 
risk–benefit balance was not possible. 
Third, the authors elected to exclude 
those cases where a prior admission had 
occurred in the previous year. This allowed 
the authors to more readily attribute 
changes in prescribing to a discrete 
admission but may have excluded patients 
with potentially more complex health needs, 
thus limiting generalisability. Average 
emergency admission length in England 
has previously been reported as 7.5 days 
in 2015/2016,26 which is slightly greater but 
nevertheless comparable with that found in 
the present study of 6.4 days.
Finally, the present study did not include 
a comparative group; therefore, the authors 
cannot be sure whether changes observed 
were attributable to the hospital admission 
or other factors that occurred in the care 
process during the same period.
Comparison with existing literature
The number of drug changes pre- and 
post-hospitalisation range from 0.227 to 5.528 
in the existing literature, with up to 75% 
of patients experiencing a change.29 The 
present study found that approximately 50% 
of patients had a change in the number of 
medications following discharge. Following 
a slight increase in prescribing immediately 
following discharge, the present study 
observed a decline 6 months later, 
consistent with a Swiss study investigating 
long-term changes to prescribing.30 Results 
indicate that initial medication changes 
are not necessarily sustained, potentially 
reflecting improvements in patients’ health 
or ongoing medicines optimisation in 
primary care. Greatest reductions were 
observed among patients with greater 
morbidity and higher levels of prescribing, 
potentially reflecting greater subsequent 
contact with health services and more 
opportunities for medication regimen 
change. 
The authors found pre-hospital PIP rates 
to be comparable with the general UK 
population (4% versus 5%).19 PIPs increased 
after discharge, consistent with observations 
elsewhere,11,12 though other studies have 
reported decreases.31–33 Disparities likely 
reflect differences in definitions of PIP 
(STOPP/Beers criteria32,33 versus RCGP 
indicators) and populations studied (older31–33 
versus general population). 
Implications for research and practice
Medication reconciliation is a key part of 
providing high-quality care and optimising 
prescribing across the primary–secondary 
care interface. The present study 
demonstrates that changes in prescribing 
post-hospitalisation are more frequent 
in patients who have fewer conditions or 
those on fewer medications pre-admission. 
This likely reflects an appropriate 
clinical response to new acute illness in 
patients who are usually relatively well, 
in comparison with a greater focus on 
deprescribing and medicines optimisation in 
more multimorbid individuals. The authors 
observed variation between specialties, 
with marked increases following discharge 
from cardiology probably reflecting the 
associated culture of evidence-based drug 
use in this specialty. 
The lack of a statistically significant 
reduction in prescribing in patients admitted 
to geriatric care is more unexpected; it may 
be a consequence of external pressures 
on services, reducing opportunities for 
medicines optimisation, though restrictions 
to the study population may also be a 
factor. Increases in PIPs post-discharge are 
unlikely to be solely a result of increased 
prescribing, but may reflect a shift in the 
risk–benefit balance of certain medications, 
favouring potentially more hazardous 
prescribing in patients who are acutely 
ill. However, it also raises concerns that 
hospital clinicians may not be adequately 
alert to PIPs, or pressures to minimise 
hospital stays may be compromising 
good pharmacological management. 
Therefore, medication optimisation should 
be considered a routine part of early post-
hospital follow-up targeted at patients most 
likely to be subject to changes in medication 
and PIPs. 
However, whether early intervention 
impacts on long-term changes in 
prescribing that were observed post-
discharge in this study is unclear and 
requires further study.
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